Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,688 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 539 of 641 · 7,688 filings

  • Kadant (KAI) FY2024 10-K risk factors
    35 risks

    This is Kadant Inc.'s initial risk filing, highlighting heavy exposure to cyclical capital equipment markets like OSB and mining.

    Filed Feb 25, 2025
  • KBR (KBR) FY2024 10-K risk factors
    38 risks

    KBR's risk profile is dominated by government contracting dependencies, fixed-price project cost overruns, and global macroeconomic and geopolitical exposures.

    Filed Feb 25, 2025
  • Keurig Dr Pepper (KDP) FY2024 10-K risk factors
    33 risks

    Supply chain disruptions and volatile input costs threaten manufacturing and distribution across core beverage lines. Changing consumer preferences, including the impact of weight loss drugs, require constant adaptation. Regulatory scrutiny over packaging, labeling, and environmental impacts creates substantial compliance burdens. Heavy reliance on third-party bottlers, distributors, and limited Asian brewer manufacturers exposes operations to external failures.

    Filed Feb 25, 2025
  • Kiniksa Pharmaceuticals International (KNSA) FY2024 10-K risk factors
    60 risks

    Single-product commercialization reliance on ARCALYST drives primary risks, including sole-source manufacturing dependencies and complex intellectual property protection.

    Filed Feb 25, 2025
  • Kontoor Brands (KTB) FY2024 10-K risk factors
    45 risks

    Customer concentration is high, with Walmart alone accounting for 36 percent of net revenues in 2024. Supply chain reliance is heavy, with approximately 70 percent of units sourced from Asia. Growth strategies include the pending acquisition of Helly Hansen and Project Jeanius.

    Filed Feb 25, 2025
  • Lucid Group (LCID) FY2024 10-K risk factors
    83 risks

    Lucid faces high operational and financial risk due to substantial ongoing net losses and limited manufacturing scale. The business depends heavily on the Lucid Air and the successful rollout of the Lucid Gravity. Growth relies on complex global supply chains and EV market adoption.

    Filed Feb 25, 2025
  • Labcorp Holdings (LH) FY2024 10-K risk factors
    42 risks

    Labcorp faces high regulatory exposure regarding laboratory-developed tests, pricing pressure from government healthcare programs, and stringent data security mandates.

    Filed Feb 25, 2025
  • LivaNova (LIVN) FY2024 10-K risk factors
    30 risks

    Medical device maker faces heavy regulatory, cybersecurity, and supply chain dependencies globally.

    Filed Feb 25, 2025
  • Pulmonx (LUNG) FY2024 10-K risk factors
    85 risks

    Pulmonx faces heavy reliance on its flagship Zephyr Valve and Chartis System for treating severe emphysema. The company has a history of significant net losses, totaling an accumulated deficit of $467.6 million as of December 31, 2024. Operations depend critically on single-source suppliers, a single headquarters manufacturing facility, and widespread physician and hospital adoption.

    Filed Feb 25, 2025
  • Luxfer Holdings (LXFR) FY2024 10-K risk factors
    29 risks

    Dependence on cyclical end markets like automotive, SCBA, aerospace, and defense dominates the risk profile.

    Filed Feb 25, 2025
  • McDonald's (MCD) FY2024 10-K risk factors
    28 risks

    Franchisee financial health and cooperation are central because McDonald’s earns most restaurant margins from franchised locations.

    Filed Feb 25, 2025
  • MidCap Financial Investment (MFIC) FY2024 10-K risk factors
    91 risks

    MFIC’s risks center on credit losses, leverage, illiquid private investments, and uncertain portfolio valuations.

    Filed Feb 25, 2025

Companies covered

4,011 companies

371 more under A